During the past decade, Meridien Research conducted 115 clinical trials. In the 10-year time frame, 115 clinical trials started and 121 clinical trials were completed, i.e. on average, 105.2% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 74 clinical trials were completed. i.e. 435.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Meridien Research" #1 sponsor was "Pfizer" with 15 trials, followed by "Eli Lilly and Company" with 8 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 8 trials sponsored, "Supernus Pharmaceuticals, Inc." with 7 trials sponsored and "Allergan" with 7 trials sponsored. Other sponsors include 150 different institutions and companies that sponsored additional 101 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Meridien Research" #1 collaborator was "CoLucid Pharmaceuticals" with 3 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator, "Integrium" with 3 trials as a collaborator, "Medpace, Inc." with 3 trials as a collaborator and "Bristol-Myers Squibb" with 2 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Meridien Research" are "Alzheimer's Disease" (21 trials), "Diabetes Mellitus, Type 2" (8 trials), "ADHD" (6 trials), "Chronic Idiopathic Constipation" (6 trials) and "Depressive Disorder, Major" (6 trials). Many other conditions were trialed in "Meridien Research" in a lesser frequency.

Most popular intervention types in "Meridien Research" are "Drug" (187 trials), "Other" (15 trials), "Biological" (7 trials), "Device" (3 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (95 trials), "placebo" (11 trials), "Metformin" (4 trials), "Rapastinel" (4 trials) and "pregabalin" (4 trials). Other intervention names were less common.

The vast majority of trials in "Meridien Research" are 180 trials for "All" genders, 13 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Meridien Research". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 157 completed trials in Meridien Research, 3 suspended trials, and 23 terminated clinical trials to date.

Out of the total trials that were conducted in Meridien Research, 3 "Phase 1" clinical trials were conducted, 79 "Phase 2" clinical trials and 111 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 3 trials that are defined as “Not Applicable".